At-home Testing Kits Market

At-home Testing Kits Market (Type of Test: DNA Testing Kits, Pregnancy Testing Kits, Infectious Disease Testing Kits, Wellness and Health Monitoring Kits, Allergy Testing Kits, and Others;) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

At-home Testing Kits Market Outlook 2034

  • The global industry was valued at US$ 7.3 Bn in 2023
  • It is expected to grow at a CAGR of 5.9% from 2024 to 2034 and reach US$ 12.3 Bn by the end of 2034

Analyst Viewpoint

Personalized healthcare is one of the factors augmenting the at-home testing kits market demand. At-home testing kits help in earlier detection of certain disorders such as higher blood pressure, higher bad cholesterol, and even developments such as pregnancy, so that treatment could be started with to avert any further complications. These kits could help in checking the infectious diseases as well.

The companies operating in at-home testing kits market are working toward devising at-home testing kits for critical ailments as well. Such kits will add to the comfort of the patients, as critical tests are still performed within the premises of hospitals and laboratories.

Moreover, increase in the production of existing at-home testing kits is on the anvil, as it would help in combating the pandemic-like situation.

At-home Testing Kits Market Overview

At-home testing kits, also called home use tests, are the kits one can purchase either online or at retail pharmacies or any other brick and mortar stores. These kits facilitate screening or monitoring of some conditions and ailments at the comfort of home.

The most common at-home tests include pregnancy tests, glucose (blood sugar) tests, fecal occult blood test (for colon cancer), tests checking for signs of hepatitis, Covid-19, and HIV, and genetic tests that would show if one is at a risk of some diseases.

Technological advancements, especially with diagnostics and biosensors, are resulting in the development of user-friendly and precise testing kits.

However, stern regulatory requirements pertaining to approval of the at-home testing kits are likely to pose a challenge to manufacturers. Besides, certain complex diagnostic tests may not be suitable for at-home use, thereby limiting scope of these kits.

Attribute Detail
Market Drivers
  • Rise in Focus on Personalized Healthcare
  • Rise in Preference for Rapid and Convenient Diagnostic Kits

Growing Emphasis on Personalized Healthcare catalyzing Demand for Home Testing Devices

The post-pandemic era has raised health consciousness amongst the individuals. Various companies have come forward to conduct research in this regard.

For instance, in February 2023, Abingdon Health plc inked a distribution agreement with Salignostics in order to extend the sales of the latter’s saliva-based pregnancy test kits all over Ireland. In May 2021, Zoe raised US$ 20 Mn for at-home testing kits.

Rise in geriatric population and increase in incidence of chronic diseases are the other factors contributing toward at-home testing kits market growth, apart from those staying in remote areas.

As per the United Nations, the number of individuals aged 65 and above are expected to increase to 1.6 billion in 2050 from 761 billion in 2021. Furthermore, the WHO states that noncommunicable diseases (NCDs) end up claiming 41 million people every year.

Need for timely intervention regarding chronic ailments and reaching out to the ones residing in far-flung areas and aged ones is thus fostering at-home testing kits market opportunities.

Increase in Preference for Rapid and Convenient Diagnostic Kits driving Demand for Self-diagnostic Kits

Initially, nasal swabs were analyzed by polymerase chain reaction (PCR) in the countries that are equipped with essential laboratory infrastructure People had to wait for longer duration to obtain results of the tests.

However, the scenario changed during as well as post-pandemic era as healthcare landscapes continued to evolve. At present, people opt for at-home diagnostic tests enabled by various technological advancements and driven by consumer expectations.

At-home testing kits can be advantageous for the ones residing in remote areas or those facing issues with mobility. These self-testing kits help in saving on travel time and provide healthcare services to these individuals at their discretion.

At-home testing kits play a vital role regarding preventive healthcare. Self-monitoring at regular intervals can result in early detection of the potential health ailments, thereby facilitating timely or before time medical intervention.

Rise in awareness regarding the benefits of self-testing kits is thus shaping the at-home testing kits market size.

Regional Analysis of At-Home Testing Kit Adoption and Usage Pattern

Attribute Detail
Leading Region North America

As per the latest at-home testing kits market analysis, North America dominated the self-testing kits landscape in 2023 and the situation is likely to persist during the forecast period. This is attributed to growing prevalence of chronic ailments that diagnosis and treatment at the earliest.

In October 2023, PHASE Scientific Americas introduced INDICAID Health, a virtual platform apprising about its at-home health tests and digital health experiences. The users, after getting test results, can get the needed guidance/advice regarding treatment through this platform.

Certain at-home testing kits facilitate multiple testing, thereby letting a single kit to assess multiple health parameters on simultaneous grounds. This, in turn, improves efficiency of testing and provides a more comprehendible health profile.

Analysis of At-Home Testing Kits Market Manufacturers

The key players in the at-home testing kits industry are involved in launching new products followed by rapid approvals to leave a stronger footprint. For instance, in May 2022, empowerDx announced that it had launched an at-home celiac disease genetic risk test kit that performs molecular testing.

Abbott Laboratories, F. Hoffmann-La Roche AG, Dräger Global, Ascensia Diabetes Care Holdings AG, ARKRAY USA, Inc., Piramal Enterprises, Mankind Pharma, OraSure Technologies, Sterilab Services, Clearblue, Chembio Diagnostics Systems, Inc., and Others are some of the key players covered in the at-home testing kits market report.

These players have been highlighted based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Competitive Landscape of the At-Home Testing Kits Market

  • In March 2022, Brain Chemistry Labs announced that it was planning to develop a rapid self-testing kit to detect β-N-methylamino-L-alanine (BMAA) in the body. This easy-to-use kit was to be developed in collaboration with Arlington Scientific.

At-home Testing Kits Market Snapshot

Attribute Detail
Market Size in 2023 US$ 7.3 Bn
Market Forecast (Value) in 2034 US$ 12.3 Bn
Growth Rate (CAGR) 5.9%
Forecast Period 2024-2034
Historical Data Available for 2020-2022
Quantitative Units US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2023)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Type of Test
    • DNA Testing Kits
    • Pregnancy Testing Kits
    • Infectious Disease testing Kits (e.g., Covid-19, STIs)
    • Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)
    • Allergy Testing Kits
    • Others
  • Technology
    • Molecular Diagnostics (PCR, qPCR)
    • Immunoassays (ELISA, lateral flow assays)
    • Microfluidics
    • Biosensors
    • Next-generation Sequencing (NGS)
    • Other Emerging Technologies
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC
Companies Profiled
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Dräger Global
  • Ascensia Diabetes Care Holdings AG
  • ARKRAY USA, Inc.
  • Piramal Enterprises
  • Mankind Pharma
  • OraSure Technologies
  • Sterilab Services
  • Clearblue
  • Chembio Diagnostics Systems, Inc.
  • Others
Customization Scope Available Upon Request
Pricing Available Upon Request

Frequently Asked Questions

How big was the global at-home testing kits market in 2023?

It was valued at US$ 7.3 Bn in 2023

How is the at-home testing kits business expected to grow during the forecast period?

It is projected to advance at a CAGR of 5.9% from 2024 to 2034

What are the key factors driving the demand for at-home testing kits?

Growing emphasis on personalized healthcare and increase in preference for rapid and convenient diagnostic kits

Which at-home testing kits technology segment held the largest share in 2023?

Molecular diagnostics accounted for the largest share in 2023

Which region dominated the global at-home testing kits landscape in 2023?

North America was the dominant region in 2023

Who are the key at-home testing kits manufacturers?

Abbott Laboratories, F. Hoffmann-La Roche AG, Dräger Global, Ascensia Diabetes Care Holdings AG, ARKRAY USA, Inc., Piramal Enterprises, Mankind Pharma, OraSure Technologies, Sterilab Services, Clearblue, Chembio Diagnostics Systems, Inc., and Others

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: At-home Testing Kits Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution/Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. At-home Testing Kits Market Analysis and Forecast, 2020-2034

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. At-home Testing Kits Market Analysis and Forecast, by Type of Test

    6.1. Introduction & Definition

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Type of Test, 2020-2034

        6.3.1. DNA Testing Kits

        6.3.2. Pregnancy Testing Kits

        6.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)

        6.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)

        6.3.5. Allergy Testing Kits

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Type of Test

7. At-home Testing Kits Market Analysis and Forecast, by Technology

    7.1. Introduction & Definition

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Technology, 2020-2034

        7.3.1. Molecular Diagnostics (PCR, qPCR)

        7.3.2. Immunoassays (ELISA, lateral flow assays)

        7.3.3. Microfluidics

        7.3.4. Biosensors

        7.3.5. Next-generation Sequencing (NGS)

        7.3.6. Other Emerging Technologies

    7.4. Market Attractiveness Analysis, by Technology

8. At-home Testing Kits Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value Forecast, by Region, 2020-2034

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Region

9. North America At-home Testing Kits Market Analysis and Forecast

    9.1. Introduction

    9.2. Key Findings

    9.3. Market Value Forecast, by Type of Test, 2020-2034

        9.3.1. DNA Testing Kits

        9.3.2. Pregnancy Testing Kits

        9.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)

        9.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)

        9.3.5. Allergy Testing Kits

        9.3.6. Others

    9.4. Market Value Forecast, by Technology, 2020-2034

        9.4.1. Molecular Diagnostics (PCR, qPCR)

        9.4.2. Immunoassays (ELISA, lateral flow assays)

        9.4.3. Microfluidics

        9.4.4. Biosensors

        9.4.5. Next-generation Sequencing (NGS)

        9.4.6. Other Emerging Technologies

    9.5. Market Value Forecast, by Country, 2020-2034

        9.5.1. U.S.

        9.5.2. Canada

    9.6. Market Attractiveness Analysis

        9.6.1. By Type of Test

        9.6.2. By Technology

        9.6.3. By Country

10. Europe At-home Testing Kits Market Analysis and Forecast

    10.1. Introduction

    10.2. Key Findings

    10.3. Market Value Forecast, by Type of Test, 2020-2034

        10.3.1. DNA Testing Kits

        10.3.2. Pregnancy Testing Kits

        10.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)

        10.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)

        10.3.5. Allergy Testing Kits

        10.3.6. Others

    10.4. Market Value Forecast, by Technology, 2020-2034

        10.4.1. Molecular Diagnostics (PCR, qPCR)

        10.4.2. Immunoassays (ELISA, lateral flow assays)

        10.4.3. Microfluidics

        10.4.4. Biosensors

        10.4.5. Next-generation Sequencing (NGS)

        10.4.6. Other Emerging Technologies

    10.5. Market Value Forecast, by Country/Sub-region, 2020-2034

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Italy

        10.5.5. Spain

        10.5.6. Rest of Europe

    10.6. Market Attractiveness Analysis

        10.6.1. By Type of Test

        10.6.2. By Technology

        10.6.3. By Country/Sub-region

11. Asia Pacific At-home Testing Kits Market Analysis and Forecast

    11.1. Introduction

    11.2. Key Findings

    11.3. Market Value Forecast, by Type of Test, 2020-2034

        11.3.1. DNA Testing Kits

        11.3.2. Pregnancy Testing Kits

        11.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)

        11.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)

        11.3.5. Allergy Testing Kits

        11.3.6. Others

    11.4. Market Value Forecast, by Technology, 2020-2034

        11.4.1. Molecular Diagnostics (PCR, qPCR)

        11.4.2. Immunoassays (ELISA, lateral flow assays)

        11.4.3. Microfluidics

        11.4.4. Biosensors

        11.4.5. Next-generation Sequencing (NGS)

        11.4.6. Other Emerging Technologies

    11.5. Market Value Forecast, by Country/Sub-region, 2020-2034

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Market Attractiveness Analysis

        11.6.1. By Type of Test

        11.6.2. By Technology

        11.6.3. By Country/Sub-region

12. Latin America At-home Testing Kits Market Analysis and Forecast

    12.1. Introduction

    12.2. Key Findings

    12.3. Market Value Forecast, by Type of Test, 2020-2034

        12.3.1. DNA Testing Kits

        12.3.2. Pregnancy Testing Kits

        12.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)

        12.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)

        12.3.5. Allergy Testing Kits

        12.3.6. Others

    12.4. Market Value Forecast, by Technology, 2020-2034

        12.4.1. Molecular Diagnostics (PCR, qPCR)

        12.4.2. Immunoassays (ELISA, lateral flow assays)

        12.4.3. Microfluidics

        12.4.4. Biosensors

        12.4.5. Next-generation Sequencing (NGS)

        12.4.6. Other Emerging Technologies

    12.5. Market Value Forecast, by Country/Sub-region, 2020-2034

        12.5.1. Brazil

        12.5.2. Mexico

        12.5.3. Rest of Latin America

    12.6. Market Attractiveness Analysis

        12.6.1. By Type of Test

        12.6.2. By Technology

        12.6.3. By Country/Sub-region

13. Middle East & Africa At-home Testing Kits Market Analysis and Forecast

    13.1. Introduction

    13.2. Key Findings

    13.3. Market Value Forecast, by Type of Test, 2020-2034

        13.3.1. DNA Testing Kits

        13.3.2. Pregnancy Testing Kits

        13.3.3. Infectious Disease Testing Kits (e.g., Covid-19, STIs)

        13.3.4. Wellness and Health Monitoring Kits (e.g., blood glucose, cholesterol)

        13.3.5. Allergy Testing Kits

        13.3.6. Others

    13.4. Market Value Forecast, by Technology, 2020-2034

        13.4.1. Molecular Diagnostics (PCR, qPCR)

        13.4.2. Immunoassays (ELISA, lateral flow assays)

        13.4.3. Microfluidics

        13.4.4. Biosensors

        13.4.5. Next-generation Sequencing (NGS)

        13.4.6. Other Emerging Technologies

    13.5. Market Value Forecast, by Country/Sub-region, 2020-2034

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Market Attractiveness Analysis

        13.6.1. By Type of Test

        13.6.2. By Technology

        13.6.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

    14.2. Market Share Analysis, by Company (2023)

    14.3. Company Profiles

        14.3.1. Abbott Laboratories

            14.3.1.1. Company Overview

            14.3.1.2. Product Portfolio

            14.3.1.3. SWOT Analysis

            14.3.1.4. Financial Overview

            14.3.1.5. Strategic Overview

        14.3.2. F. Hoffmann-La Roche AG

            14.3.2.1. Company Overview

            14.3.2.2. Product Portfolio

            14.3.2.3. SWOT Analysis

            14.3.2.4. Financial Overview

            14.3.2.5. Strategic Overview

        14.3.3. Dräger Global

            14.3.3.1. Company Overview

            14.3.3.2. Product Portfolio

            14.3.3.3. SWOT Analysis

            14.3.3.4. Financial Overview

            14.3.3.5. Strategic Overview

        14.3.4. Ascensia Diabetes Care Holdings AG

            14.3.4.1. Company Overview

            14.3.4.2. Product Portfolio

            14.3.4.3. SWOT Analysis

            14.3.4.4. Financial Overview

            14.3.4.5. Strategic Overview

        14.3.5. ARKRAY USA, Inc.

            14.3.5.1. Company Overview

            14.3.5.2. Product Portfolio

            14.3.5.3. SWOT Analysis

            14.3.5.4. Financial Overview

            14.3.5.5. Strategic Overview

        14.3.6. Piramal Enterprises

            14.3.6.1. Company Overview

            14.3.6.2. Product Portfolio

            14.3.6.3. SWOT Analysis

            14.3.6.4. Financial Overview

            14.3.6.5. Strategic Overview

        14.3.7. Mankind Pharma

            14.3.7.1. Company Overview

            14.3.7.2. Product Portfolio

            14.3.7.3. SWOT Analysis

            14.3.7.4. Financial Overview

            14.3.7.5. Strategic Overview

        14.3.8. OraSure Technologies

            14.3.8.1. Company Overview

            14.3.8.2. Product Portfolio

            14.3.8.3. SWOT Analysis

            14.3.8.4. Financial Overview

            14.3.8.5. Strategic Overview

        14.3.9. Sterilab Services

            14.3.9.1. Company Overview

            14.3.9.2. Product Portfolio

            14.3.9.3. SWOT Analysis

            14.3.9.4. Financial Overview

            14.3.9.5. Strategic Overview

        14.3.10. Clearblue

            14.3.10.1. Company Overview

            14.3.10.2. Product Portfolio

            14.3.10.3. SWOT Analysis

            14.3.10.4. Financial Overview

            14.3.10.5. Strategic Overview

        14.3.11. Chembio Diagnostics Systems, Inc.

            14.3.11.1. Company Overview

            14.3.11.2. Product Portfolio

            14.3.11.3. SWOT Analysis

            14.3.11.4. Financial Overview

            14.3.11.5. Strategic Overview

        14.3.12. Others

            14.3.12.1. Company Overview

            14.3.12.2. Product Portfolio

            14.3.12.3. SWOT Analysis

            14.3.12.4. Financial Overview

            14.3.12.5. Strategic Overview

List of Tables

Table 01: At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034

Table 02: At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034

Table 03: At-home Testing Kits Market Size (US$ Bn) Forecast, by Region, 2020-2034

Table 04: North America At-home Testing Kits Market Size (US$ Bn) Forecast, by Country, 2020-2034

Table 05: North America At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034

Table 06: North America At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034

Table 07: Europe At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 08: Europe At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034

Table 09: Europe At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034

Table 10: Asia Pacific At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 11: Asia Pacific At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034

Table 12: Asia Pacific At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034

Table 13: Latin America At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Latin America At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034

Table 15: Latin America At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034

Table 16: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034

Table 17: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast, by Type of Test, 2020-2034

Table 18: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast, by Technology, 2020-2034

List of Figures

Figure 01: At-home Testing Kits Market Size (US$ Bn) and Distribution (%), by Region, 2023 and 2034

Figure 02: At-home Testing Kits Market Revenue (US$ Bn), by Type of Test, 2023

Figure 03: At-home Testing Kits Market Value Share, by Type of Test, 2023

Figure 04: At-home Testing Kits Market Revenue (US$ Bn), by Technology, 2023

Figure 05: At-home Testing Kits Market Value Share, by Technology, 2023

Figure 06: At-home Testing Kits Market Value Share, by Region, 2023

Figure 07: At-home Testing Kits Market Value (US$ Bn) Forecast, 2020-2034

Figure 08: At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034

Figure 09: At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034

Figure 10: At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034

Figure 11: At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034

Figure 12: At-home Testing Kits Market Value Share Analysis, by Region, 2023 and 2034

Figure 13: At-home Testing Kits Market Attractiveness Analysis, by Region, 2024-2034

Figure 14: North America At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 15: North America At-home Testing Kits Market Attractiveness Analysis, by Country, 2024-2034

Figure 16: North America At-home Testing Kits Market Value Share Analysis, by Country, 2023 and 2034

Figure 17: North America At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034

Figure 18: North America At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034

Figure 19: North America At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034

Figure 20: North America At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034

Figure 21: Europe At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 22: Europe At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 23: Europe At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 24: Europe At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034

Figure 25: Europe At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034

Figure 26: Europe At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034

Figure 27: Europe At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034

Figure 28: Asia Pacific At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 29: Asia Pacific At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 30: Asia Pacific At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 31: Asia Pacific At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034

Figure 32: Asia Pacific At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034

Figure 33: Asia Pacific At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034

Figure 34: Asia Pacific At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034

Figure 35: Latin America At-home Testing Kits Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 36: Latin America At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 37: Latin America At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 38: Latin America At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034

Figure 39: Latin America At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034

Figure 40: Latin America At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034

Figure 41: Latin America At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034

Figure 42: Middle East & Africa At-home Testing Kits Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 43: Middle East & Africa At-home Testing Kits Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 44: Middle East & Africa At-home Testing Kits Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 45: Middle East & Africa At-home Testing Kits Market Value Share Analysis, by Type of Test, 2023 and 2034

Figure 46: Middle East & Africa At-home Testing Kits Market Value Share Analysis, by Technology, 2023 and 2034

Figure 47: Middle East & Africa At-home Testing Kits Market Attractiveness Analysis, by Type of Test, 2024-2034

Figure 48: Middle East & Africa At-home Testing Kits Market Attractiveness Analysis, by Technology, 2024-2034

Copyright © Transparency Market Research, Inc. All Rights reserved